by Raynovich Rod | Aug 10, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, Vaccines
August 15..Update -3…Momentum slows to a walk but XBI holds the $110 handle. XLV flat at $107 level, IBB down 0.86% to $133.30. Coronavirus stocks still within 10% of 52 week highs: HOLX,REGN; weak 2020 momentum: CEMI, INO. Vaccine stock leaders: NVAX, MRNA. Gov...
by Raynovich Rod | Aug 3, 2020 | Biopharmaceuticals, Vaccines
Update-1 Aug 6 Coronavirus Stocks Get Hit in Profit Taking Mode-Vaccine Stocks are Weak Momentum continues to ebb : XBI down 0.51% to $113.81, red screen day. Virus high fliers take a hit: BNTX down 5.19%, GNMK down 13.965, INO down 6.7%, QDEL down 5.5%. TDOC...
by Raynovich Rod | Jul 9, 2020 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro, Vaccines
Update-4 7/15 1:30P…Volatlity hits COVID vaccine players; BNTX, INO, NVAX down, MRNA up. Comment from CNBC contributor: “maybe vaccine news is priced in”, shows how hard it is to play daily news flow on coronavirus vaccine stocks. Strong Coronavirus...
